Product analysis
SAMe 200 offers a simple formula aimed at liver support, although routine detox benefits are not established. Its preparation is unspecified, limiting comparison with other SAMe products.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The SAMe preparation is not specified. That limits a meaningful comparison of its quality with other preparations.
Ingredient Transparency63
The SAMe amount is stated, helping clarify the serving. Its preparation is not named, leaving an important comparison detail unresolved.
Value For Money50
The SAMe amount offers middling value for the price. The unspecified preparation limits how closely it can be compared with alternatives.
Customer Satisfaction81
Customer feedback is positive across a substantial number of ratings. That supports an established satisfaction pattern without proving liver or detox benefits.
Product Focus72
The single ingredient gives the formula a clear liver-focused purpose. Evidence in a specific liver-disease setting does not establish routine detox benefits from this serving.
- Format
Tablet - Container
- 20 Tablet(s)
- Per serving
- $0.69
- Also available
SAMe 200$15.00- Customer rating
- 4.5 · 2,742 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
S-Adenosyl Methionine | 200 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Stabilized Salt Form
Packaging Integrity
Dose, Safety & Label Transparency88
Active Dosage Strength
Net SAMe Yield Transparency
Value50
Price Per 400mg Active Dose
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
- Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
- S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
- Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection.
- S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.